INNOVIZ TECHNOLOGIES ($INVZ) posted quarterly earnings results for Q4 2025 on Wednesday, February 25th. The company reported earnings of -$0.07 per share, beating estimates of -$0.08 by $0.01. The company also reported revenue of $12,670,000, missing estimates of $16,320,000 by $-3,650,000.
You can see Quiver Quantitative's $INVZ stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
INNOVIZ TECHNOLOGIES Hedge Fund Activity
We have seen 49 institutional investors add shares of INNOVIZ TECHNOLOGIES stock to their portfolio, and 72 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PHOENIX FINANCIAL LTD. added 3,380,238 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,883,681
- MORGAN STANLEY removed 2,493,033 shares (-47.9%) from their portfolio in Q4 2025, for an estimated $2,126,806
- MILLENNIUM MANAGEMENT LLC removed 2,459,461 shares (-51.4%) from their portfolio in Q4 2025, for an estimated $2,098,166
- STATE STREET CORP added 2,302,775 shares (+236.3%) to their portfolio in Q4 2025, for an estimated $1,964,497
- QUBE RESEARCH & TECHNOLOGIES LTD added 2,265,053 shares (+312.5%) to their portfolio in Q4 2025, for an estimated $1,932,316
- GOLDMAN SACHS GROUP INC removed 2,264,475 shares (-76.5%) from their portfolio in Q4 2025, for an estimated $1,931,823
- RENAISSANCE TECHNOLOGIES LLC added 1,928,653 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,645,333
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
INNOVIZ TECHNOLOGIES Analyst Ratings
Wall Street analysts have issued reports on $INVZ in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 11/26/2025
To track analyst ratings and price targets for INNOVIZ TECHNOLOGIES, check out Quiver Quantitative's $INVZ forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
